Financials & SEC Filings | Xeris Biopharma Holdings, Inc.

Proxy Statements

Filing date	Description	Form	View
Feb 11, 2019	CORRESP	CORRESP	View HTML 0001193125-19-034089.pdf 0001193125-19-034089.rtf 0001193125-19-034089.xls
Feb 11, 2019	CORRESP	CORRESP	View HTML 0001193125-19-034084.pdf 0001193125-19-034084.rtf 0001193125-19-034084.xls
May 30, 2018	CORRESP	CORRESP	View HTML 0001193125-18-178736.pdf 0001193125-18-178736.rtf 0001193125-18-178736.xls
Jun 01, 2018	CORRESP	CORRESP	View HTML 0001193125-18-181861.pdf 0001193125-18-181861.rtf 0001193125-18-181861.xls
Jun 18, 2018	CORRESP	CORRESP	View HTML 0001193125-18-195643.pdf 0001193125-18-195643.rtf 0001193125-18-195643.xls
Aug 19, 2019	CORRESP	CORRESP	View HTML 0001193125-19-224505.pdf 0001193125-19-224505.rtf 0001193125-19-224505.xls
May 24, 2018	CORRESP	CORRESP	View HTML 0001193125-18-173720.pdf 0001193125-18-173720.rtf 0001193125-18-173720.xls
Jun 18, 2018	CORRESP	CORRESP	View HTML 0001193125-18-195652.pdf 0001193125-18-195652.rtf 0001193125-18-195652.xls
Feb 04, 2022	CORRESP	CORRESP	View HTML 0001628280-22-001856.pdf 0001628280-22-001856.rtf 0001628280-22-001856.xls
Feb 04, 2022	CORRESP	CORRESP	View HTML 0001628280-22-001855.pdf 0001628280-22-001855.rtf 0001628280-22-001855.xls

Data provided by Kaleidoscope.